These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 7141171

  • 1. Erythromycin estolate to remain on market.
    FDA Drug Bull; 1982 Aug; 12(2):14. PubMed ID: 7141171
    [No Abstract] [Full Text] [Related]

  • 2. FDA begins proceedings to remove erythromycin estolate from market.
    FDA Drug Bull; 1979 Nov; 9(5):26-7. PubMed ID: 510836
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk-benefit equation for erythromycin estolate.
    LeBel M.
    Am J Hosp Pharm; 1980 Feb; 37(2):176, 180. PubMed ID: 7361788
    [No Abstract] [Full Text] [Related]

  • 11. Erythromycin propionate and estolate.
    Farre M.
    Lancet; 1988 Jul 02; 2(8601):45. PubMed ID: 2898648
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatotoxicity of erythromycin estolate during pregnancy.
    McCormack WM, George H, Donner A, Kodgis LF, Alpert S, Lowe EW, Kass EH.
    Antimicrob Agents Chemother; 1977 Nov 02; 12(5):630-5. PubMed ID: 21610
    [Abstract] [Full Text] [Related]

  • 16. Selection of an oral erythromycin product.
    Fraser DG.
    Am J Hosp Pharm; 1980 Sep 02; 37(9):1199-205. PubMed ID: 6998290
    [Abstract] [Full Text] [Related]

  • 17. Hepatotoxicity of erythromycin derivatives.
    Pessayre D, Benhamou JP.
    Br Med J; 1979 May 19; 1(6174):1357. PubMed ID: 445081
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Controlled study of the liver-protective effect of cycloxilic acid in a form of iatrogenic liver disease].
    Neuman M, Fluteau G.
    Clin Ter; 1978 Nov 15; 87(3):243-64. PubMed ID: 380876
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.